NEWS
Russia to Begin Human Trials of AI-Powered Cancer Vaccine in 2025

Russia is preparing to launch human trials of a groundbreaking cancer vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology—the same institute behind the Sputnik COVID-19 vaccines.
Preclinical studies have reportedly shown that the vaccine can suppress tumor growth and prevent the spread of cancer (metastasis).
The vaccine is uniquely designed for each patient, using artificial intelligence to analyze the genetic makeup of their tumors.
The first human trials, focusing on a melanoma-specific version of the vaccine, are expected to begin in late 2025 at the Hertsen Research Institute and the N.N. Blokhin National Medical Research Center in Moscow.
Discover more from Naijanewstoday
Subscribe to get the latest posts sent to your email.
-
CAMPUS REPORTS6 days ago
AE-FUNAI Mass Comm HOD Eyes Stronger Alumni, Second-Term Reforms
-
NEWS5 days ago
Foundation Flags Off ‘Back to School’ Programme in Ebonyi
-
FACT-CHECKS/INVESTIGATION7 days ago
Troops Kill Notorious Bandit Leader Kachalla Bala, Five Others in Kogi
-
POLITICS7 days ago
National Assembly Blocks Senator Natasha’s Resumption
-
FACT-CHECKS/INVESTIGATION5 days ago
Court Denies Bail to Five More Accused of Owo Church Bombing
-
SPORTS6 days ago
Nottingham Forest Appoint Ange Postecoglou as New Manager
-
NEWS5 days ago
FG Inaugurates Committee for Nigeria’s 65th Independence Celebration
-
FACT-CHECKS/INVESTIGATION6 days ago
Village Head Arrested for Allegedly Shooting Sister in Akwa Ibom
-
FACT-CHECKS/INVESTIGATION4 days ago
Ansaru Commander Mahmud Usman Jailed 15 Years
-
INSIDE NYSC5 days ago
Lagos Corps Member Emerges Runner-Up in DG’s Writing Contest
-
FOREIGN5 days ago
US Activist Charlie Kirk Shot Dead at Utah University
-
FACT-CHECKS/INVESTIGATION3 days ago
Police Kill Suspected Gang Leader in FCT Gun Battle, Recover Rifles